[HTML][HTML] Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: a cross-sectional …

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PLoS …, 2019 - journals.plos.org
Background Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …

Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis.

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - Plos one, 2019 - europepmc.org
Background Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …

[PDF][PDF] Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional …

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PLoS …, 2019 - pdfs.semanticscholar.org
Background Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …

Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis.

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PLoS …, 2019 - search.ebscohost.com
Despite recent efforts to scale-up lifelong combination antiretroviral therapy (cART) in sub-
Saharan Africa, high rates of unsuppressed viremia persist among cART users, and many …

[HTML][HTML] Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional …

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Background Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …

Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PloS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …

Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PloS one, 2019 - pure.johnshopkins.edu
Background Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …

Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: a cross-sectional analysis.

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - 2019 - cabidigitallibrary.org
Background: Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …

[引用][C] Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional …

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PLoS …, 2019 - ui.adsabs.harvard.edu
Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in
the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis - NASA/ADS …

[PDF][PDF] Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional …

P Atuhaire, S Hanley, N Yende-Zuma, J Aizire… - PLoS ONE, 2019 - academia.edu
Background Despite recent efforts to scale-up lifelong combination antiretroviral therapy
(cART) in sub-Saharan Africa, high rates of unsuppressed viremia persist among cART …